Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease
This study has been completed.
Study NCT00796679   Information provided by The University of Hong Kong

First Received on November 20, 2008.   Last Updated on May 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Disease
Additional conditions recognized in this trial
Cardiomegaly
Hypertrophy
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Pathological Conditions, Anatomical
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
paricalcitol
Additional drug interventions recognized in this trial
Ergocalciferols
More general drug interventions related to this trial
Bone Density Conservation Agents
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamins
Sponsors listed in this trial
The University of Hong Kong
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services